Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$47.1M Sell
690,853
-93,403
-12% -$6.2M 0.46% 89
2017
Q3
$49.1M Sell
784,256
-489,653
-38% -$29.3M 0.5% 90
2017
Q2
$70M Buy
1,273,909
+93,452
+8% +$4.87M 0.69% 34
2017
Q1
$59.3M Buy
1,180,457
+413,799
+54% +$20.2M 0.56% 56
2016
Q4
$38M Buy
+766,658
New +$38.9M 0.32% 123
2015
Q1
Sell
-212
Closed -$8K 1062
2014
Q4
$8K Hold
212
﹤0.01% 1065
2014
Q3
$8K Sell
212
-1,643
-89% -$61K ﹤0.01% 1092
2014
Q2
$72K Buy
+1,855
New +$69.3K ﹤0.01% 1627

Other funds holding XYL

Virtus Fund Advisers's XYL Position: Q4 2017 in Review

Virtus Fund Advisers reduced its Xylem (XYL) stake by 12% in Q4 2017, selling an estimated $6.2M and leaving 690,853 shares worth $47.1M. The position accounts for 0.46% of the portfolio, ranked #89.

Virtus Fund Advisers first reported a position in XYL in Q2 2014 and has held it in 8 quarters since. The position peaked at $70M in Q2 2017. 625 funds tracked by Wall St. Rank hold XYL as of Q4 2017.

  • Virtus Fund Advisers held 690,853 shares of Xylem worth $47.1M as of Q4 2017.
  • Virtus Fund Advisers sold 93,403 Xylem shares in Q4 2017, an estimated $6.2M.
  • Xylem made up 0.46% of Virtus Fund Advisers's portfolio in Q4 2017, its #89 holding.
  • Virtus Fund Advisers first reported a position in Xylem in Q2 2014 and has held it in 8 quarters since.
  • Virtus Fund Advisers's Xylem position peaked at $70M in Q2 2017.
  • 625 funds tracked by Wall St. Rank held Xylem as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.